Rapid Onset of Takotsubo Cardiomyopathy Induced by an Infusion Reaction to Pembrolizumab in a Patient with NSCLC

Yuki Okamatsu; Kazuya Tsubouchi; Ritsu Ibusuki; Eri Maehara-Keshino; Atsushi Shimauchi; Takafumi Kayukawa; Daisuke Eto; Katsuhiro Inoue; Taishi Harada

doi:10.1016/j.jtocrr.2020.100055

Enriched recordOpen access

Rapid Onset of Takotsubo Cardiomyopathy Induced by an Infusion Reaction to Pembrolizumab in a Patient with NSCLC

Yuki Okamatsu, Kazuya Tsubouchi, Ritsu Ibusuki, Eri Maehara-Keshino, Atsushi Shimauchi, Takafumi Kayukawa, Daisuke Eto, Katsuhiro Inoue, Taishi Harada

JTO Clinical and Research Reports2020doi:10.1016/j.jtocrr.2020.100055

Citation graph

Abstract

No public abstract is available from the verified source records.

Authors

Yuki Okamatsu#1 Kazuya Tsubouchi#2 Ritsu Ibusuki#3 Eri Maehara-Keshino#4 Atsushi Shimauchi#5 Takafumi Kayukawa#6 Daisuke Eto#7 Katsuhiro Inoue#8 Taishi Harada#9

Institutions

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

Unresolved referenced work

Kept as external metadata until matched

Immune checkpoint inhibitors and cardiovascular toxicity

10.1016/s1470-2045(18)30457-1 · 2018

Takotsubo cardiomyopathy in cancer patients

2019

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

10.1093/annonc/mdv383 · 2015

Additional external references

No additional external references are available.